Literature DB >> 8495317

Obesity: an important prognostic factor in acute pancreatitis.

I C Funnell1, P C Bornman, S P Weakley, J Terblanche, I N Marks.   

Abstract

Ninety-nine patients with acute pancreatitis in whom body mass index (BMI = weight (kg)/height2 (m2)) was measured were studied prospectively to determine the importance of obesity as a prognostic factor in this disease. Of 19 obese patients (BMI > or = 30 kg/m2), 12 developed severe pancreatitis; seven had abscesses, of whom five died, and two further patients died. In 80 non-obese patients, the incidence of severe pancreatitis (n = 5), abscess formation (n = 4) and death (n = 4) was significantly less (P = 0.0007). The mean(s.d.) BMI of 17 patients with severe acute pancreatitis was significantly higher than that in 82 patients with mild acute disease (31.2(5.6) versus 23.3(5.6) kg/m2, P < 0.001). As a single prognostic factor, obesity had a sensitivity of 63 per cent and a specificity of 95 per cent for predicting disease severity. When five obese women with gallstone pancreatitis were excluded, the sensitivity of obesity increased to 86 per cent. Severe pancreatitis occurred in all eight obese patients with disease of an alcoholic aetiology. These data suggest that increased fat deposits in the peripancreatic and retroperitoneal spaces in obese patients may increase the risk of peripancreatic fat necrosis, abscess and death. Consideration should be given to including obesity as a prognostic factor in acute pancreatitis.

Entities:  

Mesh:

Year:  1993        PMID: 8495317     DOI: 10.1002/bjs.1800800426

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  38 in total

Review 1.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

Review 2.  Management of acute pancreatitis in the first 72 hours.

Authors:  Theodore W James; Seth D Crockett
Journal:  Curr Opin Gastroenterol       Date:  2018-09       Impact factor: 3.287

3.  Acute lipotoxicity regulates severity of biliary acute pancreatitis without affecting its initiation.

Authors:  Chandra Durgampudi; Pawan Noel; Krutika Patel; Rachel Cline; Ram N Trivedi; James P DeLany; Dhiraj Yadav; Georgios I Papachristou; Kenneth Lee; Chathur Acharya; Deepthi Jaligama; Sarah Navina; Faris Murad; Vijay P Singh
Journal:  Am J Pathol       Date:  2014-06       Impact factor: 4.307

Review 4.  Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference.

Authors:  C Dervenis; C D Johnson; C Bassi; E Bradley; C W Imrie; M J McMahon; I Modlin
Journal:  Int J Pancreatol       Date:  1999-06

Review 5.  Complications of diagnostic and therapeutic ERCP.

Authors:  S A Cohen; J H Siegel; F E Kasmin
Journal:  Abdom Imaging       Date:  1996 Sep-Oct

Review 6.  The clinical significance of pancreatic steatosis.

Authors:  Mark M Smits; Erwin J M van Geenen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-02-08       Impact factor: 46.802

Review 7.  Severe acute pancreatitis: pathogenetic aspects and prognostic factors.

Authors:  Ibrahim-A Al Mofleh
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

Review 8.  The impact of obesity on the course and outcome of acute pancreatitis.

Authors:  Mohammed Abu Hilal; Thomas Armstrong
Journal:  Obes Surg       Date:  2008-01-18       Impact factor: 4.129

9.  Is obesity a significant prognostic factor in acute pancreatitis?

Authors:  C J Tsai
Journal:  Dig Dis Sci       Date:  1998-10       Impact factor: 3.199

Review 10.  Acute biliary pancreatitis: diagnosis and treatment.

Authors:  Zakaria M Hazem
Journal:  Saudi J Gastroenterol       Date:  2009 Jul-Sep       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.